Introduction
Microarray technology provides a systematic experimental access to gene regulation reflected by expression levels. The method proved its enormous potential to elucidate the nature of various biological processes within the cell and between cells at different states. Currently, applications in the classification of cancer types are of particular interest in medical diagnosis. Recent successful studies focused on acute leukemia (Getz et al., 2000; Golub et al., 1999) , multiple tumor types , colon cancer (Alon et al., 1999) as well as breast cancer (e.g. (van 't Veer et al., 2002) ). However, microarray data analyses can also address issues concerning gene interactions thereby giving deeper insight into the molecular mechanics of the cell (Bornholdt, 2001; Kato-Maeda et al., 2001; Soinov et al., 2003) .
Numerous algorithms have been proposed and effectively employed for cancer classification. The majority of them apply or combine known classification schemes developed and previously explored within other scientific areas (e.g., neuroscience). Some of these schemes include an initial dimension reduction. A very widespread technique is PCA (Principal Component Analysis) (Bicciato et al., 2003; Yeung & Ruzzo, 2001) , which transforms data to reduce dimensions and, at the same time, attempts to preserve information on the data variability.
Another technique, the PLS (Partial Least Squares) algorithm, transforms initial variables by maximizing cross-covariance with the target vector and was demonstrated to be superior to the PCA approach (Nguyen & Rocke, 2002) . Both of these methods use a complex weighted average of all genes in the initial data sets.
On the other hand, feature selection algorithms identify a subset of relevant, classifying genes. Such genes are selected according to their ability to separate different sample classes, i.e.
to distinguish between tumor types or tumors from normal tissues. Previously developed feature selection algorithms consider the individual expression profile of a gene as a classification feature. Popular methods to select for genes employ the t-statistic (Tsai et al., 2003; Wahde et al., 2002) or the Wilcoxon score test (Antoniadis et al., 2003) . In addition, the t-statistic can be used in conjunction with other methods, e.g., PLS (Nguyen & Rocke, 2002) .
A similar approach used by (Golub et al., 1999; Ramaswamy et al., 2001 ) is based on the concept of an "ideal" marker gene. The expression profile of such genes is a binary vector, where 1 is for all the samples in class A and 0 for all the samples in class B (or vice versa; "on"-"off").
The selection procedure is looking for marker genes; the genes with a profile similar to the binary expression profile. The signal-to-noise ratio measures how well the expression profile of a real gene approximates the ideal marker gene profile. The genes with the highest signal-to-noise ratio are chosen to build binary classifiers .
In this work we do not restrict the term "feature" to a single gene expression profile but rather define it as (non-linear) functions integrating several of these profiles. The functions are selected to model in mathematical terms biological relationships among these genes and thus reflect functional relations among them. This definition for the "feature" can be considered as a generalization of the previous model used by (Golub et al., 1999; Ramaswamy et al., 2001 ). The genes forming such features are presumed (and demonstrated) to be functionally related.
Violation of the functional relations in the feature makes it possible to differentiate between cancer types. A selection procedure in this context tries to identify a group of genes, which form a feature that strongly correlates with an ideal marker gene. After constructing the ideal feature space based on the training set a simple algorithm such as weighted voting can be applied for tumor classification.
Methods
In this section we introduce a new method for the construction of gene features for the classification of multiple tumor types using microarray data. The section is organized as follows: first we formulate in mathematical terms our concept of data transformation and ideal feature construction. Since for the gene expression data the number of response variables (i.e. samples/sample classes) is usually much smaller than the number of predictor variables (i.e. genes) it is possible to build ideal features in a number of alternative ways. Different criteria can be used depending on the procedures applied. In the second part of this section, we describe a new procedure for the feature selection that maximizes the margin of an ideal feature, i.e. the value that represents a distance of one particular tumor type from the others. Finally, we describe a classification procedure based on the ideal feature concept.
Definition of the ideal feature
Here, we introduce some conventions of notation used in this paper. are mapped into feature space F . The purpose of such transformation is to achieve that for every two samples of the same class the scalar product in the feature space is equal to one and for every two objects from the different classes equal to zero. This can be described by the following equations
Let us propose one of the possible approaches to construct a mapping ) ( x F , which satisfies equation (A1). We define the ideal feature vectors as binary vectors 
where l J is a set of genes that form feature l . The unity vector e is added to the model to include in the analysis features that can be transformed to the ideal by simple shift of every component. Thus, the vector Swapping of classes A and B corresponds to a renormalization of constants in (A3) and thus leads to the same classification result.
Optimization procedure for the ideal feature construction
For simplicity in this section we will consider only positive linear combinations in (A2,A3).
But this case could be easily extended to generality by adding to the input dataset a negative copy of each gene in the form A multiplication of coefficients i in (A4) on some constant t provides ( )
, for each sample k from class A, The small constant bounds deviations of solution of (A6) from the ideal feature. This constant was fixed to be 5% of 1/K, where K is the number of training set samples.
An example for the geometric interpretation of the ideal feature generation for the twoclass separation is shown in Fig. 2 
Multiple tumor classification procedure
In case of multiple tumor classification the problem (A6) is solved L times and L feature vectors 
The index of the maximum vote l indicates the predicted class for the sample k .
Results
We applied the MAMA procedure to the dataset on multiple tumor type classification ) and the dataset on acute leukemia classification (Golub et al., 1999) .
Both datasets were downloaded from http://www.genome.wi.mit.edu/MPR.
Data preprocessing and gene selection
Both analyzed datasets were subjected to prior filtering procedures. This was done to remove lowly expressed genes as well as genes invariant across samples in the training dataset. In many previous studies The first dataset ) contained about five hundred duplicated gene profiles (duplicated genes had names in the dataset with and without "-2" suffix and identical expression values). The second copy (with the "-2" suffix) of these genes was removed from the dataset.
Multiple tumor type classification
The multiple classification dataset A number of different classification procedures were applied to this dataset in the original study by ). The best result was obtained using support vector machines -78% prediction rate on the test set (12 misclassifications of 54 test samples) and 81% prediction rate on the training set using a leave-one-out cross-validation procedure (27 misclassifications of 144 training samples). Several other classification methods analyzed yielded poor results. Their prediction rates varied from 67% to 47% depending on the applied schemes and the corresponding choice of parameters.
We tested MAMA at different filter threshold values (Table 1 ). The best results were calculated using a filter threshold of 800 units (subset no 5). This filter value provided maximum prediction rates for both the leave-one-out procedure on the training set and for the prediction of the test data set. The outcome was 8 misclassifications of 54 test samples (85%) and 25 misclassifications of 144 training samples (83%). The detailed analysis of results calculated for the subset 5 is shown in the Table 2 .
To demonstrate that the proposed method identifies functionally related gene groups important to distinguish different tumors, the following procedure was applied. After constructing the ideal features for every tumor type, the genes involved in the feature were removed from the corresponding subset. Then new features were calculated from the remaining genes. The prediction power of these newly constructed features drops significantly. For example for the subset 5 the prediction rate dropped from 85% to 68% (17 misclassification out of 54 samples).
The feature profile for the CNS cancer class is shown in Fig. 3 while the functional form of the feature and the genes involved are presented in Table 3 . This feature mainly consists of genes exhibiting negative multiple correlations (positive i in the (A3)). Indeed, there are only 5 out of 23 genes with negative i and the absolute values of them are also small compared to the positive correlations (Table 3) .
Analyses of the data presented in Table 3 revealed several genes directly related to the functioning of the CNS system or/and tumor. For example, the APCL protein is a CNS-specific homologue of the adenomatous polyposis coli tumor suppressor (Nakagawa et al., 1998) . The second gene GI O60282 (Affymetrix probe setID N98707_at) represents a neuron specific member of kinesin family (Nagase et al., 1998) . The involvement of genes number #4, #5, #8, 
Acute leukemia
The acute leukemia dataset (Golub et al., 1999 ) is one of the most intensively studied. It contains expression profiles of 7129 probe sets (i.e. genes) from 72 samples collected from acute leukemia patients. 47 of these samples were diagnosed as acute lymphoblastic leukemia (ALL) and the other 25 as acute myeloid leukemia (AML). Following the experimental setup described in (Golub et al., 1999) , the dataset has been split into a training set of 38 samples (27 ALL, and 11 AML) and a test set of 34 samples (20 ALL, and 14 AML).
A number of papers reported results for various procedures such as SVM (Furey et al., 2000) , PCA (Bicciato et al., 2003) , and PLS (Nguyen & Rocke, 2002) . This set can be considered as an established benchmark for any new microarray classification procedure. Prediction rates for the test set reported previously range from 86% to 97% (Bicciato et al., 2003; Furey et al., 2000; Golub et al., 1999; Nguyen & Rocke, 2002) . On the training set using a leave-one-out crossvalidation procedure some studies achieved 100% prediction accuracy (Nguyen & Rocke, 2002) .
Our results with MAMA compare to the best ones reported so far. Table 4 summarizes the results for various filter thresholds. The test set prediction rate was 100% over a wide range of parameters. The best training set result, 98% of correct predictions, was received on a subset of 185 genes extracted with a SD threshold of 2500 units with the leave-one-out procedure.
In contrast to all previous studies, MAMA classified sample #66 (sample 28 of the test data) correctly. Hence, MAMA is the first method that achieved 100% prediction accuracy on the test set. The confidence of classification for this sample was not very high (Fig. 4 (b) ), nevertheless it was correctly predicted in a wide range of parameters. The calculated feature (Fig.   4 ) is very close to the ideal one on the training samples and demonstrates its high prediction power on the test dataset. Even though MAMA does not require genes in the feature to be differential between classes (see above), we found several genes involved in tumor growth (e. g. vimentin and thymosin beta 4) or in lymphocyte activation/function (e.g. lymphotoxin beta and natural killer cell transcript 4, Table 5 ).
Discussion
The developed method is inspired by intertwining the concepts of Support Vector Machines (SVM) (Vapnik, 1998) and Partial Least Squares (PLS) (Wold, 1966) . The linear SVM method, if applied to a two-class separation problem, maximizes the distance between a hyperplane and the closest samples from each class. This is done by means of the following optimization problem: min||w 2 || subject to y i (wx i +b) 1 for all i, where y i ={-1, 1} are the class labels. PLS, on the other hand, is a method to construct components using linear combinations of predictor variables. PLS components are constructed to maximize the sample covariance between the response values and a linear combination of predictor variables. MAMA combines features of both methods: it maximizes the margin between classes using linear combinations of predictor variables, i.e. searching among all possible gene subspaces to find the one where the margin among classes is maximal. The SVM is a quadratic problem and, as a consequence, most weights w will differ from zero. The same is true for PLS, most predictor variables with non zero weights participate in the construction of its components. Contrary to SVM and PLS, the solutions found by MAMA represent relatively small sets of predictor variables (as a consequence of the optimization of the linear programming problem).
Despite the high overall prediction ability of MAMA (85%) for the test set of , some tumor types such as breast cancer (2 out of 4 or 50% of correct predictions), bladder (33%), and pancreas (67%), were particularly poorly predicted. It is interesting that other previously used classification methods had also considerable difficulties to predict these tumor types. For example, the performance of SVM ) was 50%, 67%, and 67% for breast, bladder and pancreas cancers, respectively. An algorithm developed by (Bagirov et al., 2003) gave 25%, 33%, and 67% for the same tumor types. Such poor performance of classifiers is clearly inadequate to be used for treatment of patients in clinics. A simultaneous failure of various classification schemes can be attributed partially to a higher level of noise in these particular datasets. This can result from, e.g. complications with preparation of data samples for these particular tumor types. At the same time, since there is a significant variability of predictions across the aforementioned three methods (e.g., 33%, 67%, and 33% for bladder cancer) one can use different weighting methods to agglomerate the classifiers in order to further reduce the overall misclassification. Therefore a use of MAMA in combination with the previously described approaches could potentially lead to the development of new powerful classification schemes.
MAMA is implemented by means of mathematical programming using the commercial package Lindo (http://www.lindo.com). This package provided a high speed of the analysis. For example, a routine analysis of 2000 genes and 150 samples required less than 5s on a computer Athlon 1800. Taking into account that the speed of linear mathematical programming scales approximately linearly with the number of variables (Chvatal, 1983) , the LP represents an invaluable approach for microarray data analysis. The current version employs weighted voting (Hilliard, 1983) as the final classification method. However, any other classification method, especially more complex non-linear methods such as associative neural networks (Tetko, 2002) can be attached to MAMA's feature extraction procedure.
In summary, although several computational schemes have been applied successfully to multiple tumor type classification, most of them use information on single differentially expressed genes but neglect changes in gene interaction. The present work addresses this issue. A new classification scheme called MAMA was described and successfully tested on two publicly available datasets. The prediction accuracy of this procedure is high and robust in a wide range of tuning parameters. Moreover, the number of identified genes supposed to be involved in tumor development for every cancer type did not exceed 20-40. Table 5 . Genes participating in the classification feature from the acute leukemia dataset (subset 1). The second column specifies the Affymetrix Probe set ID and the third indicates annotation for this particular gene. The last column indicates the corresponding coefficient from (A3). Terminal transferase mRNA -0.83
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